home / stock / axdx / axdx news


AXDX News and Press, Accelerate Diagnostics Inc. From 08/10/23

Stock Information

Company Name: Accelerate Diagnostics Inc.
Stock Symbol: AXDX
Market: NASDAQ
Website: acceleratediagnostics.com

Menu

AXDX AXDX Quote AXDX Short AXDX News AXDX Articles AXDX Message Board
Get AXDX Alerts

News, Short Squeeze, Breakout and More Instantly...

AXDX - Accelerate Diagnostics, Inc. (AXDX) Q2 2023 Earnings Call Transcript

2023-08-10 20:12:05 ET Accelerate Diagnostics, Inc. (AXDX) Q2 2023 Earnings Conference Call August 10, 2023, 16:00 ET Company Participants Laura Pierson - IR Officer Jack Phillips - CEO, President & Director David Patience - CFO, Principal Financial Officer &...

AXDX - Accelerate Diagnostics GAAP EPS of -$2.36 misses by $0.96, revenue of $2.92M misses by $0.68M

2023-08-10 16:13:25 ET Accelerate Diagnostics press release ( NASDAQ: AXDX ): Q2 GAAP EPS of -$2.36 misses by $0.96 . Revenue of $2.92M (-24.4% Y/Y) misses by $0.68M . For further details see: Accelerate Diagnostics GAAP EPS of -$2.36 misses by $0.96, rev...

AXDX - Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results PR Newswire TUCSON, Ariz. , Aug. 10, 2023 /PRNewswire/ --  Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 3...

AXDX - Accelerate Diagnostics Q2 2023 Earnings Preview

2023-08-09 17:35:11 ET Accelerate Diagnostics ( NASDAQ: AXDX ) is scheduled to announce Q2 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$1.45 (-530.4% Y/Y) and the consensus Revenue Estimate is $3.6M (-6.7% Y/Y).Over the last ...

AXDX - Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results PR Newswire TUCSON, Ariz. , July 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10,...

AXDX - Accelerate Diagnostics to implement 1-for-10 reverse share split

2023-07-10 10:22:07 ET Accelerate Diagnostics ( NASDAQ: AXDX ) will conduct a reverse stock split at a ratio of 1-for-10, the company said Monday. The reverse stock split will become effective at 5:00 p.m. Eastern Time, on July 11, 2023. The reverse stock split r...

AXDX - Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split PR Newswire TUCSON, Ariz. , July 10, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) (the "Company") a leading provider of innovative rapid diagnostic solutions, announced that it wil...

AXDX - First Wave, YS Biopharma top healthcare gainers; Jin Medical, Finch Therapeutics among losers

2023-06-13 10:10:06 ET Gainers: First Wave BioPharma ( FWBI ) +150% . YS Biopharma ( YS ) +20% . Akoya Biosciences ( AKYA ) +17% . Evoke Pharma ( EVOK ) +16% . Surmodics ( SRDX ) +16% . Losers: Jin Medical International ( ...

AXDX - Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave

Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave PR Newswire TUCSON, Ariz. , June 13, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc., (NASDAQ: AXDX) a leadin...

AXDX - AXDX, ECOR and GRCL among pre-market losers

2023-06-13 08:20:35 ET Auddia ( AUUD ) -37% . Advanced Health Intelligence ( AHI ) -28% . Finch Therapeutics Group ( FNCH ) -22% . Asset Entities ( ASST ) -18% . Jin Medical International Ltd. ( ZJYL ) -16% on releasing new-generatio...

Previous 10 Next 10